Nimorazole

Revision as of 14:21, 9 April 2015 by Aparna Vuppala (talk | contribs) (Created page with "{{Drugbox | verifiedrevid = 444760513 | IUPAC_name = 4-[2-(5-nitro-1''H''-imidazol-1-yl)ethyl]morpholine | image = Nimorazol.png <!--Clinical data--> | tradename = | Drugs....")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Nimorazole
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC9H14N4O3
Molar mass226.23 g/mol
3D model (JSmol)
  (verify)

Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]

References

  1. PMID 1098732 (PMID 1098732)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  2. PMID 12559522 (PMID 12559522)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  3. Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov

Template:Agents against amoebozoa


Template:Antiinfective-drug-stub